Clinical Trial Update: Daikenchuto for Intestinal Dysmotility and Prevention of Postoperative Paralytic Ielus After Pancreaticoduodenectomy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Daikenchuto for intestinal dysmotility and prevention of postoperative paralytic ileus following pancreaticoduodenectomy; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paralytic Ileus

Drugs mentioned

• Daikenchuto (daikenchuto)

Snippet

Sponsor: Wakayama Medical University | Conditions: Paralytic Ileus | Phase 2 | Status: UNKNOWN